Science To Consumers Stock Net Income
| BEUT Stock | USD 0.0001 0.00 0.00% |
Science To's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Science Pink Sheet price.
Science |
Science to Consumers Company Net Income Analysis
Science To's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Science To Net Income | (58.7 K) |
Most of Science To's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Science to Consumers is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Science to Consumers reported net income of (58,705). This is 100.01% lower than that of the Consumer Defensive sector and 100.01% lower than that of the Household & Personal Products industry. The net income for all United States stocks is 100.01% higher than that of the company.
Science Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Science To's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Science To could also be used in its relative valuation, which is a method of valuing Science To by comparing valuation metrics of similar companies.Science To is currently under evaluation in net income category among its peers.
Science Fundamentals
| Return On Asset | -4.4 | |||
| Current Valuation | 1.18 M | |||
| Shares Outstanding | 31.92 M | |||
| Shares Owned By Insiders | 65.78 % | |||
| Price To Earning | (17.50) X | |||
| Price To Book | 955.49 X | |||
| EBITDA | (51.17 K) | |||
| Net Income | (58.7 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (47.69 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | 3.1 | |||
| Market Capitalization | 1.13 M | |||
| Total Asset | 11.73 K | |||
| Retained Earnings | (162 K) | |||
| Working Capital | (66 K) | |||
| Current Asset | 2 K | |||
| Current Liabilities | 68 K | |||
| Z Score | -37.4 | |||
| Net Asset | 11.73 K |
About Science To Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Science to Consumers's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Science To using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Science to Consumers based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Science Pink Sheet Analysis
When running Science To's price analysis, check to measure Science To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science To is operating at the current time. Most of Science To's value examination focuses on studying past and present price action to predict the probability of Science To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science To's price. Additionally, you may evaluate how the addition of Science To to your portfolios can decrease your overall portfolio volatility.